4.7 Review

Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Factors affecting the response to subthreshold micropulse laser therapy used in center-involved diabetic macular edema

Mehmed Ugur Isik et al.

Summary: The study aimed to investigate the impact of RPE status and HbA1c levels on the efficacy of SMPL in treating center-involving DME. Results revealed that the condition of central RPE could determine treatment response, with HbA1c levels possibly affecting treatment efficacy. Comparing RPE area and HbA1c levels may predict the need for a second session of SMPL treatment.

LASERS IN MEDICAL SCIENCE (2022)

Article Endocrinology & Metabolism

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naive DME Patients: Assessment by OCT Angiography

Magdalena Hunt et al.

Summary: This study evaluated the effectiveness of intravitreal bevacizumab treatment in patients with diabetic macular edema (DME) by using optical coherence tomography angiography (OCT-A) to assess retinal changes. The results showed that fixed-regimen intravitreal bevacizumab therapy was effective in treating DME, but OCT-A had limited usefulness in predicting treatment response.

JOURNAL OF DIABETES RESEARCH (2022)

Article Ophthalmology

Differential gene expression analysis using RNA sequencing: retinal pigment epithelial cells after exposure to continuous-wave and subthreshold micropulse laser

Tomoyasu Shiraya et al.

Summary: The study reveals that subthreshold micropulse laser (SMPL) is more clinically efficient than conventional continuous-wave laser (CW) for the treatment of diabetic macular edema (DME). Transcriptome changes after laser treatment were characterized and compared between the two lasers.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2022)

Article Pharmacology & Pharmacy

Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study

Vincenza Bonfiglio et al.

Summary: This study aimed to evaluate the effect of subthreshold micropulse yellow laser (SMYL) on best-corrected visual acuity (BCVA), central macular thickness (CMT), and optical coherence tomography angiography (OCT-A) in eyes with persistent diabetic macular edema (DME) after pars plana vitrectomy (PPV) for tractional DME (TDME). The results demonstrated that SMYL treatment significantly improved BCVA, reduced CMT, and increased vessel density in the superficial capillary plexus (SCP) and deep capillary plexus (DCP), as well as decreased the area of the foveal avascular zone (FAZ).

FRONTIERS IN PHARMACOLOGY (2022)

Article Ophthalmology

Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)

Keyvan Koushan et al.

Summary: The study aimed to investigate the safety and efficacy of micropulse macular laser combined with intravitreal aflibercept for center-involved diabetic macular edema. The results showed that intravitreal aflibercept injections led to improvements in visual acuity and macular thickness, and the addition of micropulse laser did not provide additional benefits in reducing treatment burden or improving macular thickness.

CLINICAL OPHTHALMOLOGY (2022)

Article Medicine, Research & Experimental

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial

Xuejing Mi et al.

Summary: This study aims to compare the efficacy of micropulse laser combined with ranibizumab treatment to ranibizumab monotherapy in the treatment of diabetic macular edema (DME), providing a new regimen for future DME treatment. Micropulse laser combined with anti-VEGF drugs can reduce the number of intraocular injections and alleviate the economic and psychological burden on patients.

TRIALS (2022)

Article Medicine, General & Internal

Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema

Lisa Toto et al.

Summary: This study compared the anatomical and functional changes after intravitreal dexamethasone implant (IDI) alone and combined with navigated subthreshold micropulse laser (NSML) in diabetic macular oedema (DMO). The results showed that the combined treatment had good outcomes for DMO and could reduce injection frequency, improving patients' quality of life.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Ophthalmology

Efficacy of subthreshold micropulse laser combined with ranibizumab in the treatment of diabetic macular edema

F. Bicak et al.

Summary: This study aimed to compare the effectiveness of micropulse laser and anti-VEGF injections in treating diabetic macular edema. The results showed that micropulse laser treatment reduced the need for anti-VEGF injections without any negative effects on visual acuity and retinal imagings.

INTERNATIONAL OPHTHALMOLOGY (2022)

Article Ophthalmology

Subthreshold yellow micropulse laser for treatment of diabetic macular edema: Comparison between fixed and variable treatment regimen

Maria Carla Donati et al.

Summary: The purpose of this study was to compare the efficacy of fixed and variable treatment regimens for diabetic macular edema. The results showed that both treatment regimens were effective for mild center-involving diabetic macular edema, with the fixed treatment regimen appearing more suitable for minimizing treatment time and reducing errors.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Multidisciplinary Sciences

Comparison of short-pulse subthreshold (532 nm) and infrared micropulse (810 nm) macular laser for diabetic macular edema

Abdulrahman Al-Barki et al.

Summary: The study aimed to compare the anatomical and functional outcomes of short-pulse continuous wavelength and infrared micropulse lasers in the treatment of diabetic macular edema (DME). The results suggest that the infrared micropulse system may improve functional outcomes, while the short-pulse system may lead to temporary reduction in edema. The study concludes that the two laser therapy methods have some differences in treating DME.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update

Andrzej Grzybowski et al.

Summary: Macular edema is commonly caused by retinal vein occlusion and diabetes, with anti-VEGF intravitreal injections replacing laser photocoagulation as the primary treatment. However, this treatment may require frequent injections and some patients may not respond well, indicating the need for alternative therapies and potential future use of artificial intelligence in treatment selection.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Engineering, Biomedical

Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema

Meltem Guzin Altinel et al.

Summary: This study found that adding SML to IVB therapy can significantly reduce the need for IVB, although a very significant increase in BCVA cannot be achieved. The use of SML-IVB combined treatment may be an effective and safe alternative for DME.

LASERS IN MEDICAL SCIENCE (2021)

Article Chemistry, Medicinal

Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema

Wataru Kikushima et al.

Summary: The study found that red and yellow SMPL treatments for DME had similar efficacy over a 1-year period, maintaining best-corrected visual acuity and reducing central retinal thickness effectively.

PHARMACEUTICALS (2021)

Review Ophthalmology

Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045 Systematic Review and Meta-analysis

Zhen Ling Teo et al.

Summary: The translated paragraphs provide updated estimates on the global prevalence and number of people with diabetic retinopathy (DR) through 2045. The burden of DR is expected to increase disproportionately in countries in the Middle East and North Africa and the Western Pacific by 2045. Certain ethnic groups such as Hispanics and Middle Easterners with diabetes are more likely to have DR compared to Asians.

OPHTHALMOLOGY (2021)

Review Medicine, General & Internal

Subthreshold Diode Micropulse Laser Combined with Intravitreal Therapy for Macular Edema-A Systematized Review and Critical Approach

Maciej Gawecki

Summary: Combining subthreshold diode micropulse laser with intravitreal anti-VEGF or steroid therapy may reduce the number of intravitreal injections needed for treating macular edema secondary to retinal vascular disease, while maintaining good functional and morphological outcomes. Further randomized research is necessary to confirm the potential benefits of this combination therapy.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Health Care Sciences & Services

Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study

Luisa Frizziero et al.

Summary: This study evaluated the long-term efficacy and safety of 577-nm SMPL treatment for mild DME in a real-life setting, showing significant improvement in visual acuity and reduction in retinal thickness without requiring intravitreal injections. The results suggest that 577-nm SMPL is a safe and repeatable option for mild DME treatment in clinical practice.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Endocrinology & Metabolism

Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Lesley A. Everett et al.

Summary: In summary, laser therapy continues to play a critical role in the treatment of diabetic retinopathy and diabetic macular edema, with combination therapy using pharmacologic treatment showing improved clinical efficacy and outcomes. Continued innovations in laser technology and improved understanding of laser-retinal interactions will further enhance the effectiveness of laser therapy in the future.

CURRENT DIABETES REPORTS (2021)

Article Ophthalmology

Comparison of two-year treatment outcomes between subthreshold micropulse (577 nm) laser and aflibercept for diabetic macular edema

Frank Hiu Ping Lai et al.

Summary: Aflibercept achieved faster and higher rates of anatomical and functional improvement compared to micropulse laser in DME patients, but there were no significant differences in long-term efficacy between aflibercept monotherapy and micropulse laser.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2021)

Article Multidisciplinary Sciences

Changes in entropy on polarized-sensitive optical coherence tomography images after therapeutic subthreshold micropulse laser for diabetic macular edema: A pilot study

Koji Ueda et al.

Summary: This study investigated the dynamics of healing process after SMPL treatment for DME using PS-OCT, revealing changes in entropy value in the RPE and a positive correlation between retinal thickness change rate and RPE entropy change within the SMPL-irradiated sector.

PLOS ONE (2021)

Review Medicine, General & Internal

Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema

Luisa Frizziero et al.

Summary: Subthreshold micropulse laser treatment has shown potential in treating diabetic macular edema, but its mechanism of action and most effective treatment methods are not yet fully understood, requiring further research. The treatment appears to normalize specific retinal neuroinflammatory metabolic pathways long-term, contributing to the restoration of retinal homeostasis and the curtailing of local inflammatory processes. Optimized and standardized parameters are key to ensuring effective and safe treatment.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Ophthalmology

Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up

Leila El Matri et al.

Summary: The combination therapy of IVB and MPL for central diffuse DME shows effectiveness in improving BCVA and CMT over 12 months, with significantly fewer injections in the IVB + MPL group compared to the IVB group.

THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)

Article Ophthalmology

Real-life outcomes of subthreshold laser therapy for diabetic macular edema

Renato M. Passos et al.

Summary: This study evaluated the efficacy of subthreshold laser therapy in real-life setting for center-involving DME. Results showed that cases associated with SFR had the best anatomical response, while intraretinal edema responded poorly to laser monotherapy. The study suggests that combined treatment may be needed for most patients due to mild response in BCVA and macular thickness.

INTERNATIONAL JOURNAL OF RETINA AND VITREOUS (2021)

Article Ophthalmology

Micropulse laser in patients with refractory and treatment-naive center-involved diabetic macular edema: short terms visual and anatomic outcomes

Diego Alejandro Valera-Cornejo et al.

Summary: The study demonstrated that micropulse 577nm laser therapy can maintain visual acuity and macular thickness at 3 months in both treatment-naive and refractory DME patients. Significant changes in central macular thickness were observed at 3 months in the treatment-naive group, but not clinically significant.

THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)

Article Ophthalmology

Investigation of the therapeutic mechanism of subthreshold micropulse laser irradiation in retina

Kazutaka Hirabayashi et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)

Article Ophthalmology

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES AFTER SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA

Stela Vujosevic et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)

Article Ophthalmology

Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers

Stela Vujosevic et al.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)

Review Ophthalmology

Macular laser photocoagulation in the management of diabetic macular edema: Still relevant in 2020?

Marcelo Zas et al.

TAIWAN JOURNAL OF OPHTHALMOLOGY (2020)

Article Ophthalmology

Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema

Abeer M. Khattab et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)

Review Medicine, General & Internal

Micropulse Laser Treatment of Retinal Diseases

Maciej Gawecki

JOURNAL OF CLINICAL MEDICINE (2019)

Article Ophthalmology

Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema

Elad Moisseiev et al.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2018)

Article Ophthalmology

Short-term Efficacy of Micropulse Yellow Laser in Non-center-involving Diabetic Macular Edema: Preliminary Results

Mehmet Fatih Kagan Degirmenci et al.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY (2018)

Review Ophthalmology

Application of subthreshold laser therapy in retinal diseases: a review

Spencer M. Moore et al.

EXPERT REVIEW OF OPHTHALMOLOGY (2018)

Review Medicine, General & Internal

Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis

Gianni Virgili et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Review Medicine, Research & Experimental

A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders

Paula Scholz et al.

ADVANCES IN THERAPY (2017)

Review Ophthalmology

A Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology

Daniel Su et al.

OPHTHALMOLOGY AND THERAPY (2017)

Article Environmental Sciences

Subthreshold micropulse yellow 577 nm laser therapy of diabetic macular oedema in rural and urban patients of south-eastern Poland

Malgorzata Latalska et al.

ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2017)

Review Ophthalmology

Subthreshold Diode Micropulse Laser: A Review

Hilary S. Brader et al.

SEMINARS IN OPHTHALMOLOGY (2016)

Article Ophthalmology

Yellow micropulse laser in diabetic macular edema: a short-term pilot study

Massimo Nicolo et al.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2014)

Article Ophthalmology

SAFETY OF TRANSFOVEAL SUBTHRESHOLD DIODE MICROPULSE LASER FOR FOVEA-INVOLVING DIABETIC MACULAR EDEMA IN EYES WITH GOOD VISUAL ACUITY

Jeffrey K. Luttrull et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)

Article Ophthalmology

The Comparative Histologic Effects of Subthreshold 532-and 810-nm Diode Micropulse Laser on the Retina

Alfred K. Yu et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)

Article Ophthalmology

ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS A Six-Year Experience at a University Referral Center

Andrew A. Moshfeghi et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)

Article Ophthalmology

Randomized Clinical Trial Evaluating mETDRS versus Normal or High-Density Micropulse Photocoagulation for Diabetic Macular Edema

Daniel Lavinsky et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)

Article Ophthalmology

Subthreshold Micropulse Diode Laser Photocoagulation for Diabetic Macular Edema in Japanese Patients

Kishiko Ohkoshi et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)

Review Ophthalmology

Micropulsed Diode Laser Therapy: Evolution and Clinical Applications

Sobha Sivaprasad et al.

SURVEY OF OPHTHALMOLOGY (2010)

Article Ophthalmology

Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients

H Funatsu et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2005)